Efficacy and Safety of Dulaglutide Monotherapy Compared to Glimepiride in Oral Antihyperglycemic Medication-Naïve Chinese patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN1-Reference-Cited by-同舟云学术

Efficacy and Safety of Dulaglutide Monotherapy Compared to Glimepiride in Oral Antihyperglycemic Medication-Naïve Chinese patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN1

Published:2020-03-26 Issue:5 Volume:11 Page:1077-1090
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Li Yi Ming,Zhang Li Hui,Li Xue Jun,Zhang Bin,Hou Jia Ning,Tong Nan Wei

Funder

Lilly Suzhou Pharmaceutical Co. Ltd

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13300-020-00799-w.pdf

Reference39 articles.

1. Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;27:2515–23.

2. Hu C, Jia W. Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes. 2018;67:3–11.

3. Vilsbøll T. The effects of glucagon-like peptide-1 on the beta cell. Diabetes Obes Metab. 2009;11:11–8.

4. UK Prospective Diabetes Study Group. UKPDS 16: overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes. 1995;44:1249–58.

5. DeFronzo R, Abdul-Ghani MA. Preservation of β-cell function: the key to diabetes prevention. J Clin Endrocinol Metab. 2011;96:2354–66.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tune-out wavelengths of Rydberg atoms;Acta Physica Sinica;2024

2. Effects of once‐weekly glucagon‐like peptide‐1 receptor agonists on type 2 diabetes mellitus complicated with coronary artery disease: Potential role of the renin‐angiotensin system;Diabetes, Obesity and Metabolism;2023-08-02

3. GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway;Journal of Diabetes Research;2022-11-03

4. Association of Dulaglutide Initiation Timing With Treatment Patterns and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus in the United States;Clinical Therapeutics;2022-06